<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Three blood markers of <z:mp ids='MP_0001845'>inflammation</z:mp> (high-sensitivity C-reactive protein [hsCRP], interleukin [IL]-6, and fibrinogen) were compared with markers of <z:e sem="disease" ids="C0003972" disease_type="Disease or Syndrome" abbrv="ascvd">atherosclerotic cardiovascular disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>) (history of <z:hpo ids='HP_0001297'>stroke</z:hpo> or <z:mp ids='MP_0004120'>cardiac ischemia</z:mp> and measured toe-brachial index [TBI]) to determine whether inflammatory markers are associated with <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: Of 103 patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, 26 had <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>TBI was plethysmographically determined in both great toes </plain></SENT>
<SENT sid="3" pm="."><plain>Serum hsCRP was immunonephelometrically determined </plain></SENT>
<SENT sid="4" pm="."><plain>Plasma IL-6 was measured by an enzyme immunoassay </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Both ABI and TBI were lower in diabetic patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> than in those without <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> (1.05 +/- 0.19 vs. 1.14 +/- 0.09, P &lt; 0.05, and 0.75 +/- 0.20 vs. 0.95 +/- 0.21, P &lt; 0.001, respectively) </plain></SENT>
<SENT sid="6" pm="."><plain>By linear regression, right TBI but not right ABI showed a significant negative correlation with serum hsCRP (r = -0.372, P &lt; 0.01) and plasma fibrinogen (r = -0.224, P &lt; 0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>Serum hsCRP was also negatively correlated with lower TBI, but not lower ABI </plain></SENT>
<SENT sid="8" pm="."><plain>We found no significant correlation between plasma IL-6 and ABI or TBI </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: TBI was strongly associated with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>, serum hsCRP, and plasma fibrinogen </plain></SENT>
<SENT sid="10" pm="."><plain>Of these inflammatory markers, serum hsCRP may be the most promising marker for <z:mp ids='MP_0001863'>vascular inflammation</z:mp> </plain></SENT>
</text></document>